667, L.P.
SEC CIK 1551139 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| INCY | Incyte | Dir, 10% | 28.18M | $143.66M | — | 10 | 2021-12-15 | 2025-03-31 |
| IMCR | Immunocore Holdings plc | Dir | 2.05M | $23.99M | — | 1 | 2025-03-17 | 2025-03-17 |
| KYMR | Kymera Therapeutics, Inc. | Dir | 5.52M | $46.41 | — | 1 | 2024-08-20 | 2024-08-20 |
| BCYC | BICYCLE THERAPEUTICS PLC | Dir, 10% | 788.0K | — | — | 1 | 2024-06-17 | 2024-06-17 |
| VTVT | vTv Therapeutics Inc. | Dir | 89.3K | — | — | 1 | 2024-03-05 | 2024-03-05 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Dir | 1.67M | $7.55M | — | 1 | 2023-12-12 | 2023-12-12 |
| ONC | BeOne Medicines Ltd. | Dir, 10% | 93.4K | — | — | 2 | 2022-06-22 | 2023-06-15 |
| KNSA | Kiniksa Pharmaceuticals International, plc | Dir | 117.7K | — | — | 1 | 2023-06-06 | 2023-06-06 |
| ACAD | ACADIA PHARMACEUTICALS INC | Dir, 10% | 39.03M | $22.71M | — | 2 | 2023-05-22 | 2023-05-23 |
| TCRX | TScan Therapeutics, Inc. | Dir, 10% | 1.75M | $23.93M | — | 2 | 2021-07-20 | 2022-05-10 |
| KOD | Kodiak Sciences Inc. | Dir, 10% | 13.14M | $10.01M | — | 1 | 2021-08-17 | 2021-08-17 |
Most active insiders at INCY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hoppenot Herve | Dir | — | $19.77M |
| 2 | CAGNONI PABLO J | Pres, R, D | — | $14.10M |
| 3 | Stein Steven H | EVP, Chief Medical Off | — | $7.86M |
| 4 | Mayes Patrick A | EVP, CSO | — | $6.56M |
| 5 | Morrissey Michael James | EVP, Head of Tech. Ops | — | $5.68M |
| 6 | Clancy Paul J | Dir | — | $1.42M |
| 7 | Issa Mohamed Khairie | EVP, Head of US Oncology | — | $1.31M |
| 8 | Tray Thomas | Principal Accounting Off | — | $879.0K |
| 9 | Denton Sheila A. | EVP, GC | — | $465.2K |
| 10 | Heeson Lee | EVP, Head of Incyte Intl | — | $289.0K |
667, L.P. made no open-market trades at INCY in the last 12 months.
Transactions 23
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-04-02 | 2025-03-31 | INCY | Incyte | 667, L.P. | Dir, 10% | A - Grant | $0.00 | +974 | 28.18M | +0.0% | $0 |
| DMI | 2025-03-19 | 2025-03-17 | IMCR | Immunocore Holdings plc | 667, L.P. | Dir | P - Purchase | $29.72 | +807.3K | 2.05M | +65% | +$23.99M |
| DI | 2024-08-22 | 2024-08-20 | KYMR | Kymera Therapeutics, Inc. | 667, L.P. | Dir | P - Purchase | $46.41 | +1 | 5.52M | +0.0% | +$46.41 |
| DMI | 2024-06-20 | 2024-06-17 | BCYC | BICYCLE THERAPEUTICS PLC | 667, L.P. | Dir, 10% | C - Cnv Deriv | $0.00 | +2.38M | 788.0K | New | $0 |
| MI | 2024-04-01 | 2024-03-28 | INCY | Incyte | 667, L.P. | Dir, 10% | A - Grant | $0.00 | +1,086 | 33.45M | +0.0% | $0 |
| DMI | 2024-03-07 | 2024-03-05 | VTVT | vTv Therapeutics Inc. | 667, L.P. | Dir | D - Sale to Iss | $0.00 | -57.7K | 89.3K | -39% | $0 |
| MI | 2024-01-03 | 2023-12-29 | INCY | Incyte | 667, L.P. | Dir, 10% | A - Grant | $0.00 | +1,112 | 2.97M | +0.0% | $0 |
| MI | 2023-12-14 | 2023-12-12 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | 667, L.P. | Dir | P - Purchase | $218.31 | +34.6K | 1.67M | +2% | +$7.55M |
| MI | 2023-10-03 | 2023-09-29 | INCY | Incyte | 667, L.P. | Dir, 10% | A - Grant | $0.00 | +1,020 | 33.45M | +0.0% | $0 |
| DMI | 2023-06-20 | 2023-06-15 | ONC | BeOne Medicines Ltd. | 667, L.P. | Dir, 10% | A - Grant | $0.00 | +51.7K | 93.4K | +124% | $0 |
| DMI | 2023-06-08 | 2023-06-06 | KNSA | Kiniksa Pharmaceuticals International, plc | 667, L.P. | Dir | A - Grant | $0.00 | +17.5K | 117.7K | +17% | $0 |
| DMI | 2023-05-24 | 2023-05-22+ | ACAD | ACADIA PHARMACEUTICALS INC | 667, L.P. | Dir, 10% | P - Purchase | $25.33 | +896.5K | 39.03M | +2% | +$22.71M |
| DMI | 2023-05-24 | 2023-05-23 | ACAD | ACADIA PHARMACEUTICALS INC | 667, L.P. | Dir, 10% | M - OptEx | $17.01 | +25.0K | 38.62M | +0.1% | +$425.3K |
| MI | 2022-10-04 | 2022-09-30 | INCY | Incyte | 667, L.P. | Dir, 10% | A - Grant | $0.00 | +914 | 33.42M | +0.0% | $0 |
| DMI | 2022-06-24 | 2022-06-22 | ONC | BeOne Medicines Ltd. | 667, L.P. | Dir, 10% | A - Grant | $0.00 | +66.8K | 67.6K | +8,294% | $0 |
| DMI | 2022-06-17 | 2022-06-15 | INCY | Incyte | 667, L.P. | Dir, 10% | A - Grant | $0.00 | +4,288 | 2.94M | +0.1% | $0 |
| MI | 2022-05-12 | 2022-05-10+ | TCRX | TScan Therapeutics, Inc. | 667, L.P. | Dir, 10% | P - Purchase | $1.88 | +1.36M | 1.75M | +351% | +$2.56M |
| MI | 2022-04-04 | 2022-03-31 | INCY | Incyte | 667, L.P. | Dir, 10% | A - Grant | $0.00 | +880 | 33.42M | +0.0% | $0 |
| DMI | 2022-03-10 | 2022-03-08+ | INCY | Incyte | 667, L.P. | Dir, 10% | P - Purchase | $72.24 | +389.1K | 33.42M | +1% | +$28.11M |
| DMI | 2022-03-10 | 2022-03-08 | INCY | Incyte | 667, L.P. | Dir, 10% | M - OptEx | $22.05 | +40.0K | 33.06M | +0.1% | +$882.0K |
| MI | 2021-12-17 | 2021-12-15+ | INCY | Incyte | 667, L.P. | Dir, 10% | P - Purchase | $72.43 | +1.60M | 29.40M | +6% | +$115.56M |
| MI | 2021-08-19 | 2021-08-17+ | KOD | Kodiak Sciences Inc. | 667, L.P. | Dir, 10% | P - Purchase | $87.50 | +114.4K | 13.14M | +0.9% | +$10.01M |
| DMI | 2021-07-22 | 2021-07-20 | TCRX | TScan Therapeutics, Inc. | 667, L.P. | Dir | P - Purchase | $15.00 | +1.43M | 1.32M | New | +$21.38M |
Purchase Sale Sale after option exercise All abbreviations